What is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the natural GLP-1 hormone. It's FDA-approved for type 2 diabetes and weight management, offering powerful appetite control and metabolic benefits.
Key Benefits
⚖️ Weight Loss
Promotes significant, sustainable weight loss through appetite regulation
🍽️ Appetite Control
Reduces hunger and increases feelings of fullness
🩸 Blood Sugar
Improves insulin sensitivity and glucose control
❤️ Cardiovascular
Reduces cardiovascular risk factors
🔥 Metabolism
Enhances metabolic function and fat oxidation
🧠 Food Cravings
Reduces food cravings and emotional eating
How It Works
Semaglutide activates GLP-1 receptors in the brain, pancreas, and GI tract. This slows gastric emptying, increases insulin secretion when needed, and directly affects appetite centers in the brain to reduce hunger.
Typical Dosing Protocol
Dose: Start 0.25 mg weekly, titrate up to 1.0-2.4 mg weekly
Administration: Subcutaneous injection once weekly
Duration: Long-term use for weight management
Research Support
Extensive clinical trials show Semaglutide produces average weight loss of 15-20% of body weight. It's one of the most studied and proven weight management interventions with excellent safety data.